Overview
Bertrand Baujat practices in Paris, France. Mr. Baujat is rated as an Advanced expert by MediFind in the treatment of Parathyroid Hyperplasia. His top areas of expertise are Salivary Gland Tumors, Adenoid Cystic Carcinoma, Sinus Cancer, Glossectomy, and Laryngectomy.
His clinical research consists of co-authoring 78 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Parathyroid Hyperplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Salivary Gland TumorsMr. Baujat isDistinguished. Learn about Salivary Gland Tumors.
- Advanced
- Adenoid Cystic CarcinomaMr. Baujat isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Parathyroid HyperplasiaMr. Baujat isAdvanced. Learn about Parathyroid Hyperplasia.
- Sinus CancerMr. Baujat isAdvanced. Learn about Sinus Cancer.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adult Soft Tissue SarcomaMr. Baujat isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorMr. Baujat isExperienced. Learn about Bone Tumor.
- CellulitisMr. Baujat isExperienced. Learn about Cellulitis.
- ChondrosarcomaMr. Baujat isExperienced. Learn about Chondrosarcoma.
- Epithelial-Myoepithelial CarcinomaMr. Baujat isExperienced. Learn about Epithelial-Myoepithelial Carcinoma.